Prostate Cancer VL

Staging High-Risk Prostate Cancer with PSMA PET: Strengths and Pitfalls - Irene Burger

Details
Irene Burger discusses the significant impact of PSMA PET in diagnosing high-risk localized prostate cancer. Dr. Burger describes the rapid adoption of this technology in Switzerland, emphasizing its enhanced sensitivity over traditional imaging since its integration in 2016. Dr. Burger highlights the broad acceptance and crucial insights from significant studies, such as the proPSMA trial, which...

Local Therapy in mHSPC: Who Does Really Benefit? - Alberto Bossi

Details
Alicia Morgans and Alberto Bossi discuss the integration of local prostate treatment in metastatic hormone-sensitive prostate cancer, focusing on findings from the PEACE-1 trial and related studies. Professor Bossi highlights the challenge in identifying patients who could benefit most from local radiotherapy, especially given the evolution in imaging technologies like PSMA PET, which may redefine...

A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy - Beyond the Abstract

Details
Although there has been a single retrospective study published of salvage SBRT after brachytherapy, re-irradiation post-brachytherapy (PMID: 36739178) is largely unstudied. Here we present the first prospective trial for salvage SBRT paradigm after brachytherapy, NCT03253744. Biographies: Krishnan R. Patel, MD, Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD Related Content...

Novel 18-Gene Urine Test Improves Detection of Clinically Significant Prostate Cancer - Jeffrey Tosoian

Details
Jeffrey Tosoian presents a new tool in prostate cancer diagnosis with the development and validation of an 18-gene urine test designed to identify clinically significant prostate cancer published in JAMA Oncology. This research, supported by the Prostate Cancer Foundation (PCF) and the NCI Early Detection Research Network, introduces a novel approach to enhancing the accuracy of prostate cancer de...

A US Real-World Study of Treatment Patterns and Outcomes in Localized or Locally Advanced Prostate Cancer Patients - Beyond the Abstract

Details
Men with localized or locally advanced prostate cancer (LPC/LAPC) are at risk of progression after radiotherapy (RT) or radical prostatectomy (RP). Using real-world data, we evaluated patient characteristics, treatment patterns, and outcomes in LPC/LAPC. Biographies: Stephen J. Freedland, MD, Urologist, Cedars-Sinari, Los Angeles, CA, Staff Physician, Durham VA Medical Center, Durham, NC. Related...

The Lancet Commission on Prostate Cancer - Nicholas James & James N'Dow

Details
Nicholas James and James N'Dow delve into the findings and objectives of the Lancet Prostate Cancer Commission. Professor James outlines the initiative's global scope and multidisciplinary approach to tackling prostate cancer, emphasizing the diverse representation and expertise spanning various regions and specialties. The discussion highlights the comprehensive analysis undertaken over three yea...

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes - Nicholas Zorko

Details
Nicholas Zorko discusses the promising role of natural killer (NK) cells in prostate cancer, described his team’s study published in Prostate Cancer and Prostatic Diseases. The research reveals that increased NK cell infiltration in prostate tumors correlates with improved patient outcomes, suggesting NK cells as a potential next frontier in cellular therapies for prostate cancer. The study utiliz...

CEASAR Study Reveals Long-Term Quality of Life Outcomes for Localized Prostate Cancer Treatments - Daniel Barocas & Bashir Al Hussein Al Awamlh

Details
Alicia Morgans hosts Daniel Barocas and Bashir Al Hussein Al Awamlh to discuss findings from the CEASAR study published in JAMA, which explores long-term quality of life outcomes for men with localized prostate cancer. Initiated by Dave Penson, this longitudinal study aims to enhance shared decision-making in treatment by providing data on the side effects of various prostate cancer treatments. Fo...

Representation Matters: Trust in Digital Health Information Among Black Patients with Prostate Cancer - Stacy Loeb

Details
Stacy Loeb discusses her study on digital health information trust among Black prostate cancer patients, published in the Journal of Urology. Dr. Loeb's research reveals a stark lack of racial and ethnic diversity in online prostate cancer content, which significantly impacts trust among Black patients. This study, underpinned by analysis of social network use and content representation, involves...

The STEEL Trial: Evaluating Enzalutamide Plus ADT with Salvage RT for High-Risk Recurrent Prostate Cancer - Edwin Posadas

Details
Edwin Posadas delves into the complexities and aspirations of the STEEL RTOG 3506 trial, a study initiated as a follow-up to the RTOG 9601 trial's insights into androgen ablation's role in improving outcomes for men undergoing salvage radiation therapy post-biochemical relapse. The STEEL trial, aiming to harness more intensive AR blockade techniques available in modern medicine, embarked on explor...